Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Hulic ¥97 billion common stock offering
We advised international joint lead managers on the global offering of common stock
Uniti $700 million notes offering
We advised Uniti on its high-yield senior notes offering
Life Time $702 million IPO
We advised the underwriters on the IPO and NYSE listing
Nippon Steel ¥300 billion convertible notes offering
We advised the joint lead managers and joint bookrunners on the unregistered convertible notes offering
Manchester United secondary offering
We advised the underwriter on the SEC-registered stock offering
Enphys Acquisition Corp. $345 million IPO
We advised the underwriters on the SPAC IPO and NYSE listing
Nuvei $425 million U.S. IPO
We advised Nuvei on its U.S. IPO and Nasdaq listing of subordinate voting shares
AGCO €600 million senior notes offering
We advised the initial purchasers on an unregistered investment-grade euro debt offering
Hennessy Capital Investment VI $300 million IPO
We advised the underwriters on the SPAC IPO and Nasdaq listing
Match Group stock and notes offerings to repurchase exchangeable notes
We advised Match Group on its registered direct and senior notes offerings to repurchase exchangeable notes for $1.5 billion